Clinical Trials
3
Active:0
Completed:0
Trial Phases
2 Phases
Phase 2:2
Phase 3:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (3 trials with phase data)• Click on a phase to view related trials
Phase 2
2 (66.7%)Phase 3
1 (33.3%)Bone Healing Accelerant (BHA) Versus Autologous Bone Grafting (ABG) for Hindfoot or Ankle Arthrodesis
Phase 2
Withdrawn
- Conditions
- Foot Deformities
- First Posted Date
- 2024-02-14
- Last Posted Date
- 2024-02-14
- Lead Sponsor
- Carmell Therapeutics Corporation
- Registration Number
- NCT06258499
Multiregion BHA in Open Tibia Fractures
Phase 2
Withdrawn
- Conditions
- Tibial Fractures
- First Posted Date
- 2019-08-14
- Last Posted Date
- 2024-02-08
- Lead Sponsor
- Carmell Therapeutics Corporation
- Registration Number
- NCT04056429
Bone Healing Accelerant Versus Standard of Care for Open Tibia Fractures
Phase 3
Withdrawn
- Conditions
- Tibial Fractures
- First Posted Date
- 2019-02-01
- Last Posted Date
- 2020-01-23
- Lead Sponsor
- Carmell Therapeutics Corporation
- Registration Number
- NCT03826784
- Locations
- 🇺🇸
Carmell Therapeutics, Pittsburgh, Pennsylvania, United States
News
No news found